These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13899389)

  • 21. [Changes of the antiheparin activity of plasma and lymph in dogs subjected to whole-body irradiation. II (author's transl)].
    Klír P; Pospísil J; Skala E; Dienstbier Z; Tachecí O
    Sb Lek; 1977 Sep; 79(9):276-82. PubMed ID: 918543
    [No Abstract]   [Full Text] [Related]  

  • 22. [RESEARCH ON THE ANTIHEPARIN ACTIVITY OF PHOSPHOLIPIDS. I. ACTION OF BLOOD PLATELETS AND THEIR PHOSPHOLIPID SUBSTITUTES ON INHIBITION OF TROMBOPLASTIN FORMATION BY HEPARIN].
    ASCARI E; BARBIERI U; GOBBI F
    Prog Med (Napoli); 1964 Aug; 20():531-5. PubMed ID: 14256537
    [No Abstract]   [Full Text] [Related]  

  • 23. Action of antiheparin and heparin-like dyes on microorganisms.
    MARUZZELLA JC
    Arzneimittelforschung; 1961 Dec; 11():1095-6. PubMed ID: 14470667
    [No Abstract]   [Full Text] [Related]  

  • 24. [RESEARCH ON THE ANTIHEPARIN ACTIVITY OF PHOSPHOLIPIDS. II. ACTION OF PLATELETS AND THEIR PHOSPHOLIPID SUBSTITUTES ON PROACCELERIN INHIBITION BY HEPARIN].
    ASCARI E; BARBIERI U; GOBBI F
    Prog Med (Napoli); 1964 Sep; 20():580-3. PubMed ID: 14258160
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antiheparin and heparin activity of blood in various stages of pregnancy].
    Kreminskaia IaM
    Pediatr Akus Ginekol; 1970; 4():33-5. PubMed ID: 5504823
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of dilute solutions of formaldehyde as an antiheparin agent.
    TIMMIS HH; PESKIN GW; ORLOFF MJ
    Surg Forum; 1960; 10():432-5. PubMed ID: 13838445
    [No Abstract]   [Full Text] [Related]  

  • 27. ANTIHEPARIN AND ANTIFIBRINOLYTIC ACTIVITY OF BLOOD IN PATIENTS WITH ATHEROSCLEROSIS.
    MYASNIKOV AL; CHAZOV EI
    Am Heart J; 1964 Jan; 67():18-22. PubMed ID: 14110659
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antiheparin activity of the aneurysm wall and parietal thrombus and blood plasma of patients with aortic aneurysm].
    Gacko M; Worowska A; Kowalewski R; Guzowski A; Lapiński R; Panek B
    Przegl Lek; 2006; 63(2):58-60. PubMed ID: 16967710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT).
    Bode AP; Castellani WJ; Hodges ED; Yelverton S
    Thromb Haemost; 1991 Aug; 66(2):213-7. PubMed ID: 1771614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antiheparin activity of polymyxin M].
    ZOLOTUKHIN SI
    Antibiotiki; 1960; 5():13-7. PubMed ID: 13788776
    [No Abstract]   [Full Text] [Related]  

  • 31. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antagonistic effects of heparin and protamine sulfate on the electrophoretic mobility of blood platelets].
    Larcan A; Stoltz JF; Alexandre P
    Pathol Biol (Paris); 1969; 17(15):729-32. PubMed ID: 4907905
    [No Abstract]   [Full Text] [Related]  

  • 33. The antiheparin effect of alpha 1-acid glycoprotein, evaluated by the activated partial thromboplastin time and by a factor Xa assay for heparin.
    Andersen P
    Haemostasis; 1980; 9(5):303-9. PubMed ID: 7409614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complexoproductive and antiheparin properties of low density lipoproteins (LDL). V. Optimum conditions of the coagulation method to determine antiheparin activity in the blood plasma.
    Rółkowski R; Worowski K; Skrzydlewski Z
    Ann Med Univ Bialyst Pol; 1993; 38(1):51-5. PubMed ID: 7922485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: Response of normal and pathological platelets to heparin added in vitrio and in vivo.
    David JL; Herion FP
    Thromb Diath Haemorrh; 1975 Sep; 34(1):341. PubMed ID: 1188778
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiheparin and hemagglutinating activities of polybrene.
    LALEZARI P; SPAET TH
    J Lab Clin Med; 1961 Jun; 57():868-73. PubMed ID: 13758393
    [No Abstract]   [Full Text] [Related]  

  • 37. Neutralization of the antiheparin activity of platelet factor 4 by a monoclonal antibody.
    Saggin L; Cazzola F; Corona G; Salvatico E; Cella G; Prosdocimi M
    Thromb Haemost; 1992 Jan; 67(1):137-43. PubMed ID: 1377413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relations between the thromboplastin and anti-heparin functions of the platelets in thrombopathic and thrombopenic syndromes in childhood].
    VECCHIO F; SCHETTINI F
    Pediatria (Napoli); 1958; 66(5):697-705. PubMed ID: 13613820
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical use of polybrene as an antiheparin agent in open heart surgery.
    BLUMBERG JB; WINTERSCHEID LC; DILLARD DH; VETTO RR; MERENDINO KA
    J Thorac Cardiovasc Surg; 1960 Mar; 39():330-6. PubMed ID: 13801711
    [No Abstract]   [Full Text] [Related]  

  • 40. [A comparative study of the antiheparin activity and acute toxicity of stellins].
    Grigorova LV; Rozkin MIa; Rybin VK; Efimov VS; Makarov NV
    Farmakol Toksikol; 1990; 53(6):31-3. PubMed ID: 2081565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.